Pharma Capital
Showing 9 of 9
Name Market Market Cap Share Price Daily Share Movement
ahz[LOGO]200x100.jpg Admedus Ltd ASX £40.11m £0.16 1.96% ico_glass.png
cdy[LOGO]200x100.jpg Cellmid Ltd ASX £15.59m £0.01 0.00% ico_glass.png
Cynata.png Cynata Therapeutics ASX £34.36m £0.38 -3.82% ico_glass.png
au_novogen__120x60.jpg Novogen ASX £11.70m £0.02 2.56% ico_glass.png
par[LOGO]200x100.jpg Paradigm Biopharmaceuticals Ltd ASX £24.07m £0.24 -2.50% ico_glass.png
Pharmaxis---200x100.jpg Pharmaxis Ltd ASX £52.27m £0.16 -1.82% ico_glass.png
au_piqlogo_new120x60.jpg Proteomics International Laboratories ASX £7.68m £0.13 -2.27% ico_glass.png
rgs[LOGO]200x100.jpg Regeneus Ltd ASX £18.34m £0.09 0.00% ico_glass.png
thc[LOGO]200x100.jpg The Hydroponics Company Ltd ASX £21.35m £0.16 0.00% ico_glass.png

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.